Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo

View ORCID ProfileHoracio Almanza-Reyes, View ORCID ProfileSandra Moreno, View ORCID ProfileIsmael Plascencia-López, View ORCID ProfileMartha Alvarado-Vera, Leslie Patrón-Romero, View ORCID ProfileBelén Borrego, View ORCID ProfileAlberto Reyes-Escamilla, View ORCID ProfileDaniel Valencia-Manzo, View ORCID ProfileAlejandro Brun, View ORCID ProfileAlexey Pestryakov, View ORCID ProfileNina Bogdanchikova
doi: https://doi.org/10.1101/2021.05.20.21256197
Horacio Almanza-Reyes
1Cluster de Bioeconomía de Baja California, A.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Horacio Almanza-Reyes
  • For correspondence: almanzareyes@hotmail.com almanzareyes@hotmail.com
Sandra Moreno
2Centro de Investigación en Sanidad Animal. Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria. Carretera de Valdeolmos-El Casar s/n Valdeolmos 28130. Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sandra Moreno
  • For correspondence: brun@inia.es
Ismael Plascencia-López
3Faculty of Accounting and Administration, Autonomous University of Baja California; C.P.22390, Tijuana, Baja California, Mexico;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ismael Plascencia-López
  • For correspondence: ismael@uabc.edu.mx
Martha Alvarado-Vera
1Cluster de Bioeconomía de Baja California, A.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martha Alvarado-Vera
  • For correspondence: almanzareyes@hotmail.com
Leslie Patrón-Romero
4Faculty of Medicine and Psychology, Autonomous University of Baja California; C.P.22390, Tijuana, Baja California, Mexico;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leslie.patron@uabc.edu.mx
Belén Borrego
2Centro de Investigación en Sanidad Animal. Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria. Carretera de Valdeolmos-El Casar s/n Valdeolmos 28130. Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Belén Borrego
  • For correspondence: brun@inia.es
Alberto Reyes-Escamilla
5Tijuana General Hospital; C.P. 22000, Tijuana, Baja California, Mexico;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Reyes-Escamilla
  • For correspondence: direccion_sub_hgt@hotmail.com
Daniel Valencia-Manzo
5Tijuana General Hospital; C.P. 22000, Tijuana, Baja California, Mexico;
6Nursing Postgraduate, Iberoamericana University, Mexico City, C.P. 22500 Tijuana, Baja California, México;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Valencia-Manzo
  • For correspondence: direccion_sub_hgt@hotmail.com daniel.valencia@tijuana.ibero.mx
Alejandro Brun
2Centro de Investigación en Sanidad Animal. Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria. Carretera de Valdeolmos-El Casar s/n Valdeolmos 28130. Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alejandro Brun
  • For correspondence: brun@inia.es
Alexey Pestryakov
7Tomsk Polytechnic University; C.P. 634050, Tomsk, Russia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexey Pestryakov
  • For correspondence: pestryakov2005@yandex.ru
Nina Bogdanchikova
8Center of Nanoscience and Nanotechnology; UNAM (CNyN-UNAM), C.P.22860, Ensenada, Baja California, Mexico;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nina Bogdanchikova
  • For correspondence: nina@cnyn.unam.mx
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV-2 infection in hospital areas is of a particular concern, since the close interaction between health care personnel and patients diagnosed with COVID-19, which allows virus to be easily spread between them and subsequently to their families and communities. Preventing SARS-CoV-2 infection among healthcare personnel is essential to reduce the frequency of infections and outbreaks during the pandemic considering that they work in high-risk areas. In this research, silver nanoparticles (AgNPs) were tested in vitro and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, we assess the effects of mouthwash and nose rinse with ARGOVIT® silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as high-risk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19. We present a prospective randomized study of 231 participants that was carried out for 9 weeks (during the declaration of a pandemic). The “experimental” group was instructed to do mouthwash and nose rinse with the AgNPs solution; the “control” group was instructed to do mouthwashes and nose rinse in a conventional way. The incidence of SARS-CoV-2 infection was significantly lower in the “experimental” group (two participants of 114, 1.8%) compared to the “control” group (thirty-three participants of 117, 28.2%), with a 84.8% efficiency. We conclude that the mouth and nasal rinse with AgNPs helps in the prevention of SARS-CoV-2 infection in health personnel who are exposed to patients diagnosed with COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04894409

Funding Statement

A. Pestryakov Project VIU-RSCBMT-197/2020 Tomsk Polytechnic University https://tpu.ru/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The in vivo study was approved by the Research Ethics Committee of General Tijuana Hospital of the Institute of Public Health Services of the State of Baja California with favorable opinion number CONBIOETICA-02-CEI-001-20170 and was conducted in accordance with the Declaration of Helsinki. The favorable opinion was obtained written, we attach a copy in the support information.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available by the corresponsal author, please contact via e-mail almanzareyes@hotmail.com

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo
Horacio Almanza-Reyes, Sandra Moreno, Ismael Plascencia-López, Martha Alvarado-Vera, Leslie Patrón-Romero, Belén Borrego, Alberto Reyes-Escamilla, Daniel Valencia-Manzo, Alejandro Brun, Alexey Pestryakov, Nina Bogdanchikova
medRxiv 2021.05.20.21256197; doi: https://doi.org/10.1101/2021.05.20.21256197
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo
Horacio Almanza-Reyes, Sandra Moreno, Ismael Plascencia-López, Martha Alvarado-Vera, Leslie Patrón-Romero, Belén Borrego, Alberto Reyes-Escamilla, Daniel Valencia-Manzo, Alejandro Brun, Alexey Pestryakov, Nina Bogdanchikova
medRxiv 2021.05.20.21256197; doi: https://doi.org/10.1101/2021.05.20.21256197

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1955)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11118)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3192)
  • Geriatric Medicine (309)
  • Health Economics (565)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (788)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12738)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2999)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5609)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (764)
  • Rheumatology (340)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)